Background
Juvenile idiopathic arthritis (JIA) refers to all types of arthritis that begin before the age of 16 and last more than 6 weeks, with no known cause. The 14-3-3 η eta protein is a new biomarker linked to the development of rheumatoid arthritis and joint destruction. We sought to evaluate the 14-3-3 η eta protein’s potential as a diagnostic biomarker for JIA and its correlation with both functional outcome and disease activity.
Results
Significant levels of 14-3-3 η eta protein were found in rheumatoid factor (RF)-positive polyarticular JIA and RF-negative polyarticular JIA patients. Enthesitis-related arthritis (ERA) is associated with the lowest value of 14-3-3 η eta. 14-3-3 eta protein was significantly positively linked with CHAQ and JADAS 27 (p = 0.008 & 0.001, respectively).
Conclusion
The 14-3-3 η eta protein could be used as a biomarker to diagnose and monitor JIA. Significant levels of 14-3-3 η eta protein can be found in RF-positive polyarticular JIA and RF-negative polyarticular JIA patients. The 14-3-3 η eta protein correlates positively with disease activity and functional outcome in JIA.
Cite this Article (APA)
Khaled, O. E. Z., Yasser, A. A., Nashwa, I. H., Inas, A. A., Noha, H. I. (2025). Study of 14-3-3 η eta protein in juvenile idiopathic arthritis. Egyptian Rheumatology and Rehabilitation. https://doi.org/10.1186/s43166-025-00338-0
